PRE 14A

Proxy Statement (Preliminary)

Avalo Therapeutics, Inc. Filed 2023-10-05 Acc 0001628280-23-033960

Documents 1

PRE 14A Proxy Statement (Preliminary) , pre14a-2023a.htm

Around this filing

2024-06-07 PRE 14A Proxy Statement (Preliminary)
2023-10-05 PRE 14A Proxy Statement (Preliminary)
2023-10-03 8-K Director nominations
2022-04-04 PRE 14A Proxy Statement (Preliminary)

Link to a passage

External

SEC EDGAR (opens in new tab)